Fungal microbiota in newborn infants with and without respiratory distress syndrome

Vicente Friaza1,2, Pilar Rojas3, Carmen de la Horra2

  • 1Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, Madrid, Spain.

Plos One
|April 10, 2024
PubMed
Abstract

Insights

This study describes the airway fungal microbiota in term and preterm newborns. While no significant differences were found, certain fungi like Pneumocystis jirovecii were unique to preterm infants, suggesting a link to prematurity.

Area of Science:

  • Neonatal Medicine
  • Microbiology
  • Pulmonology

Background:

  • Pneumocystis jirovecii infection is linked to neonatal respiratory distress syndrome and bronchopulmonary dysplasia in preterm infants.
  • Airway bacterial microbiota changes are noted in infants with bronchopulmonary dysplasia.
  • No prior data existed on the airway mycobiota in newborns.

Purpose of the Study:

  • To characterize the airway fungal microbiota in both term and preterm newborns.
  • To investigate the potential association between airway mycobiota and respiratory distress syndrome.

Main Methods:

  • Molecular identification techniques were used on nasal aspirate samples collected at birth.
  • Study included 26 matched preterm infants (with and without respiratory distress syndrome) and 13 term infants.

Main Results:

  • Ascomycota was present in 89.7% and Basidiomycota in 33.3% of newborns.
  • Cladosporium was the most common genus in both groups (38.4% term vs. 73% preterm).
  • Candida sake and Pneumocystis jirovecii were exclusively found in preterm infants, indicating a potential prematurity risk association.

Conclusions:

  • This is the first study to report on the airway fungal microbiota in term and preterm infants with and without respiratory distress syndrome.
  • No significant differences in fungal microbiota were observed between groups.
  • Larger studies are required to confirm findings and elucidate the role of airway mycobiota in neonatal respiratory conditions.